Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline

Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline

Photo by RephiLe on Unsplash

Eudora Wang

29 November, 2022

antibodybiopharmaceuticalbiotechGree Financial InvestmentKingray CapitalTrinomab Biotech

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.